Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function

Launched by SUN YUTING · Feb 4, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of Hyperbaric Oxygen Therapy (HBOT) on patients who have suddenly lost their hearing, a condition known as Sudden Sensorineural Hearing Loss (SSNHL). The goal is to find out if HBOT can help improve hearing outcomes and the body's ability to manage blood clotting in these patients. Researchers will compare the results of patients who receive HBOT with those who do not, to see if there is a noticeable difference in recovery.

To participate in this trial, individuals must be between 18 and 75 years old and have experienced sudden hearing loss in one ear for the first time within the last two weeks. However, those with other ear problems, serious health conditions, or certain exclusions like being pregnant or having mental health issues will not be eligible. Participants can expect to undergo assessments and treatments as part of the study, which is not yet recruiting participants. This trial aims to gather valuable information that could help improve treatment options for people facing sudden hearing loss.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Meet the diagnostic criteria for sudden deafness in the American Academy of Otolaryngology Head and Neck Surgery 2019 Clinical Practice Guidelines for Sudden Deafness;
• • Aged 18-75 years old;
• • Patients with unilateral sudden deafness for the first time, and the onset time is less than 2 weeks.
• Exclusion Criteria:
• • Patients with other ear diseases, such as auditory trauma, barotrauma, retrocochlear disease, bilateral hearing loss, history of chronic otitis media in the same ear, and history of surgery in the same ear;
• • Patients with serious primary diseases such as heart, liver, kidney dysfunction and hematopoietic system diseases;
• • Pregnant and nursing patients;
• • Accompanied by serious mental illness;
• • Patients with incomplete clinical data.